SLC2A1, also known as glucose transporter type 1 (GLUT1), is well characterized in cancer and is associated with tumor progression and metastasis (Yan et al., 2015; Nagarajan et al., 2017; Xiao et al., 2018), including in LUAD where is has previously been shown to be upregulated and associated with poorer prognosis (Guo et al., 2020). The gene discussed is SLC2A1; the disease is neoplasm.